Want to join the conversation?
$DGX 2Q15 PR: Net revenues for the quarter were $1,925MM compared to $1,902MM in 2Q14, grew by 1.2% versus the prior year and grew 0.8% on an organic basis. Net income attributable to Quest Diagnostics was $118MM compared to $133MM in 2Q14. Adjusted net income for the quarter was $170MM compared to $157MM in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?